These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19843880)

  • 41. Thalidomide: current therapeutic uses and management of its toxicities.
    Tariman JD
    Clin J Oncol Nurs; 2003; 7(2):143-7. PubMed ID: 12696209
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thalidomide. A new beginning.
    Valorie AM
    Cancer Pract; 2000; 8(2):101-3. PubMed ID: 11898173
    [No Abstract]   [Full Text] [Related]  

  • 43. Mechanism of action of thalidomide and 3-aminothalidomide in multiple myeloma.
    D'Amato RJ; Lentzsch S; Anderson KC; Rogers MS
    Semin Oncol; 2001 Dec; 28(6):597-601. PubMed ID: 11740816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunomodulatory drugs.
    Crane E; List A
    Cancer Invest; 2005; 23(7):625-34. PubMed ID: 16305990
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Thalidomide: new perspectives for its use as antiinflammatory, immunossupressive and antiangiogenic drug].
    Borges Lde G; Frõehlich PE
    Rev Assoc Med Bras (1992); 2003; 49(1):96-102. PubMed ID: 12724820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.
    Hodowanec AC; Han A; Barker DE; Rubinstein PG; Max B
    J Int Assoc Physicians AIDS Care (Chic); 2012; 11(6):345-7. PubMed ID: 22930795
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thalidomide: emerging role in cancer medicine.
    Richardson P; Hideshima T; Anderson K
    Annu Rev Med; 2002; 53():629-57. PubMed ID: 11818493
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical pharmacology of thalidomide.
    Eriksson T; Björkman S; Höglund P
    Eur J Clin Pharmacol; 2001 Aug; 57(5):365-76. PubMed ID: 11599654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thalidomide in cancer.
    Singhal S; Mehta J
    Biomed Pharmacother; 2002 Feb; 56(1):4-12. PubMed ID: 11905508
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Potential novel uses of thalidomide: focus on palliative care.
    Peuckmann V; Fisch M; Bruera E
    Drugs; 2000 Aug; 60(2):273-92. PubMed ID: 10983733
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Recent Advances in the Development of Thalidomide-Related Compounds as Anticancer Drugs.
    Barbarossa A; Iacopetta D; Sinicropi MS; Franchini C; Carocci A
    Curr Med Chem; 2022; 29(1):19-40. PubMed ID: 34165402
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Management of thalidomide toxicity.
    Ghobrial IM; Rajkumar SV
    J Support Oncol; 2003; 1(3):194-205. PubMed ID: 15334875
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Advances in thalidomide therapy for idiopathic myelofibrosis].
    Song L; Chen JL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):651-3. PubMed ID: 19968089
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Theoretical basis for the activity of thalidomide.
    Meierhofer C; Dunzendorfer S; Wiedermann CJ
    BioDrugs; 2001; 15(10):681-703. PubMed ID: 11604049
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thalidomide: chemistry, therapeutic potential and oxidative stress induced teratogenicity.
    Kumar N; Sharma U; Singh C; Singh B
    Curr Top Med Chem; 2012; 12(13):1436-55. PubMed ID: 22650376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Thalidomide: new indications?
    Combe B
    Joint Bone Spine; 2001 Dec; 68(6):582-7. PubMed ID: 11809002
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of action of immunomodulatory agents in multiple myeloma.
    Reske T; Fulciniti M; Munshi NC
    Med Oncol; 2010 Jun; 27 Suppl 1(Suppl 1):S7-13. PubMed ID: 20405248
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thalidomide and analogues: current proposed mechanisms and therapeutic usage.
    Brennen WN; Cooper CR; Capitosti S; Brown ML; Sikes RA
    Clin Prostate Cancer; 2004 Jun; 3(1):54-61. PubMed ID: 15279692
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thalidomide: from tragedy to promise.
    von Moos R; Stolz R; Cerny T; Gillessen S
    Swiss Med Wkly; 2003 Feb; 133(5-6):77-87. PubMed ID: 12644961
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thalidomide: a novel template for anticancer drugs.
    Stirling D
    Semin Oncol; 2001 Dec; 28(6):602-6. PubMed ID: 11740817
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.